Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00159406 · ClinicalTrials.gov registry record
Laser Prostatectomy Database and Registry
A clinical trial of Benign Prostatic Hyperplasia and Enlarged Prostate, sponsored by Indiana Kidney Stone Institute.
- Active
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00159406 is a study of Benign Prostatic Hyperplasia and Enlarged Prostate that is active but no longer recruiting, run by Indiana Kidney Stone Institute. The registered enrollment target is 3,000 participants, above the 449-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (568% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00159406, a study of Benign Prostatic Hyperplasia and Enlarged Prostate, is active but no longer recruiting, sponsored by Indiana Kidney Stone Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
STATEMENT OF PURPOSE: Transurethral resection of the prostate (TURP) is the standard surgical intervention for obstructive benign prostatic hyperplasia (BPH) in all but the largest of glands, which are typically treated with open simple prostatectomy. Recently, new generation lasers (holmium and potassium titanyl phosphate \[KTP\]) have been utilized for BPH treatment. Long-term follow-up of laser prostatectomy outcomes must be documented to fully characterize the degree of voiding improvement achievable by these new techniques, the durability of these outcomes, and the safety profiles of these procedures.
Conditions Studied
Interventions
- OTHER Registry and Database
Study Locations (1)
Indiana
- IU Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2003-10 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00159406
The ClinicalTrials.gov registry entry for NCT00159406 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 449-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (568% higher). The listed sponsor is Indiana Kidney Stone Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Registry and Database is the first listed.
NCT00159406 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00159406 about?
NCT00159406 is a clinical study titled "Laser Prostatectomy Database and Registry". STATEMENT OF PURPOSE: Transurethral resection of the prostate (TURP) is the standard surgical intervention for obstructive benign prostatic hyperplasia (BPH) in all but the largest of glands, which are typically treated with open simple prostatectomy. Recently, new generation lasers (holmium and po...
What is the current status of trial NCT00159406?
This trial is currently active not recruiting. The enrollment target is 3,000 participants. The study started on 2003-10. Estimated completion is 2025-12.
What conditions does trial NCT00159406 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Enlarged Prostate.
What interventions are being tested in trial NCT00159406?
The interventions under investigation include: Registry and Database (OTHER).
Who is sponsoring clinical trial NCT00159406?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00159406 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Customized TULSA-PRO Ablation Registry
RECRUITING
-
OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
RECRUITING
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.